Skip to main content
Caplight Logo









Genomadix Inc.

Genomadix Inc.

Private
KanataHealthcare & Life Scienceshttps://genomadix.com/

Last Round

Strategic

Aug 29, 2022

Total Funding Raised

$5.8M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Genomadix Inc. is a medical diagnostics company developing a portable, real-time PCR platform designed for point-of-need genetic testing in areas like precision medicine and infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Precision Medicine, Biotechnology

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales, Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

point-of-care testingpharmacogenetic testingPOC testingPGx testingportable molecular diagnosticsrapid genetic testingreal-time PCRqPCRCYP2C19 testingsample-to-result platformprecision medicinecardiology diagnosticsstroke diagnosticsmedical devicedisposable test cartridgesopen platform diagnosticstelestrokerazor and blade model

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genomadix Inc. Comparables

Compare Genomadix Inc. with similar companies based on industry and business-model similarity.

Genomadix Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
genedrive plc
84%
Rover Diagnostics
82%
SD Biosensor Inc
77%

Genomadix Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicAug 29, 2022
SeedJul 21, 2022

Key People

Founding team and executive leadership

Adam Kuehl

Chief Financial Officer

Executive Team

Bern Johnson

Chief Operating Officer

Executive Team

Paul Markell

COO

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Open roles increased to 6, 2.1x the trailing average.

  • Jul 26, 2026

    Monthly visitors grew 68% MoM.

Genomadix Inc. Filings

Explore SEC and related filing metadata, where available.

Genomadix Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Genomadix Inc.'s valuation, stock price, and market status.

Is Genomadix Inc. a public or private company?

Genomadix Inc. is a private company.

What is the current stock price of Genomadix Inc.?

Genomadix Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Genomadix Inc. worth (valuation)?

Valuation information for Genomadix Inc. is not publicly available.

Can I buy Genomadix Inc. stock?

Genomadix Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Genomadix Inc.'s last funding round?

Genomadix Inc.'s most recent funding round was Strategic on August 29, 2022.

Who are the main investors in Genomadix Inc.?

Investor information for Genomadix Inc. is not publicly disclosed.

Will Genomadix Inc. IPO soon?

No public IPO plans have been announced for Genomadix Inc..

How can I track Genomadix Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Genomadix Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersKanata
Employee Range36
Year Founded2021
Last FundingAug 29, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?